ClinicalTrials.govpublic full text
Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections
carbapenem-resistant enterobacteriaceae infection, kpc, gram-negative bacterial infections, antibiotic resistant infection
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 411241
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.